Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 13 (10), 405-411
- https://doi.org/10.1016/0167-5699(92)90091-k
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐IJapanese Journal of Cancer Research, 1992
- Lymphocyte transformation and thiol compounds: The role of ADF/thioredoxin as an endogenous reducing agentMolecular Immunology, 1992
- Redox Regulation of Fos and Jun DNA-Binding Activity in VitroScience, 1990
- Interleukin‐2 Receptor β‐Chain (p70–75) Expressed on Leukemic Cells from Adult T Cell Leukemia PatientsJapanese Journal of Cancer Research, 1990
- Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B‐type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signalsEuropean Journal of Immunology, 1989
- Differential effects on expression of IL‐2 receptors (p55 and p70) by the HTLV‐I pX DNAInternational Journal of Cancer, 1988
- Serum Soluble Interleukin‐2 Receptor Levels in Patients with Adult T‐cell Leukemia and Human T‐cell Leukemia/Lymphoma Virus Type‐I Seropositive Healthy CarriersJapanese Journal of Cancer Research, 1988
- Close association between interleukin 2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients.Journal of Clinical Investigation, 1988
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985